author-photo

Merrill J. Egorin

University of Pittsburgh

330

Papers

13308

Citations

Citation Trend

Filter By

Papers (248) Sort By

Journal Conference Others

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (Journal of Neuro-Oncology, (2019), 143, 3, (573-581), 10.1007/s11060-019-03194-z)

2019 Journal of Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (1)
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

2019 Journal of Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (3)
Effect of age on the pharmacokinetics of busulfan (Bu): An alliance study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of renal function in patients entered onto CTEP-sponsored phase I studies since 1979

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
A phase I study of the combination of a DNA topoisomerase inhibitor, idarubicin, with the histone deacetylase inhibitor vorinostat, in advanced acute leukemia

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Phase 1 dose-escalation study of 17-allylamino-17-demethoxygeldanamycin (17AAG) in combination with irinotecan in patients with solid tumors

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance)

2013 Pharmacogenetics and Genomics
Show All
- Source
- Cite
- Save
Citations (23)
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis

2013 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (44)
In vitro Cytotoxicity, Pharmacokinetics, Tissue Distribution, and Metabolism of Small-Molecule Protein Kinase D Inhibitors, kb-NB142-70 and kb-NB165-09, in Mice bearing Human Cancer Xenografts

2013 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (16)
Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.

2013 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (5)